Tuberculosis (TB) still remains an important infectious disease and health problem worldwide in 2010. The estimates of its global burden from the World Health Organization (WHO, Geneva, Switzerland) in 2009 were 9.4 million incident cases, 14 million prevalent cases, and 1.68 million deaths (with 0.38 million in HIV-positive individuals). Drug resistance and HIV coinfection continue to pose a challenge to the global control of TB. These scenarios have underscored the tremendous enthusiasm sustaining TB research globally and in the United States. In addition, the prevalence of infection/disease due to nontuberculous mycobacteria (NTM) is escalating in various parts of the globe. In 2010, 24 studies on TB and NTM were published in the Journal . These articles are reviewed, alongside others published elsewhere, in this current update.
No takes yet. Share an insight, caveat, or question.
Yew et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: